☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Abeona Therapeutics
Abeona Therapeutics Collaborates with Beacon Therapeutics to Develop AAV204 Capsid for Certain Ophthalmology Indications
July 12, 2024
Abeona Signs a License and Inventory Purchase Agreements with Taysha for ABO-202 to Treat CLN1 Disease (Infantile Batten disease)
August 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
